Cargando…
A Broad Safety Assessment of the Recombinant Herpes Zoster Vaccine
The recombinant herpes zoster vaccine (RZV), approved as a 2-dose series in the United States in October 2017, has proven highly effective and generally safe. However, a small risk of Guillain-Barré syndrome after vaccination was identified after approval, and questions remain about other possible a...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071519/ https://www.ncbi.nlm.nih.gov/pubmed/35152283 http://dx.doi.org/10.1093/aje/kwac030 |